ConductScience.org, home

Paper2407050

Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.

Tsementzis SA and 2 others. Acta Neurochir (Wien), 1990. Cited by 66 papers, by iCite.

Cite this record

ConductScience Library. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Papers, record 2407050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2407050

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.
PubMed
Journal
Acta Neurochir (Wien)
PubMed
Year
1990
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
66
iCite
Relative citation ratio, by iCite
3.04
iCite
Revised in PubMed
2019-08-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tsementzis SAS A
2Hitchcock ERE R
3Meyer CHC H

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclohexanecarboxylic AcidsMajor topic
Subarachnoid HemorrhageMajor topic
Tranexamic AcidMajor topic
Adult
Aged
Brain Ischemia
Cerebrovascular Circulation
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Hydrocephalus
Intracranial Aneurysm
Male
Middle Aged
Postoperative Complications
Prognosis
Recurrence
Rupture, Spontaneous

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1436386Acute delirious state after epsilon-amino caproic acid administration.Clin Toxicol1979https://conductscience.org/library/papers/436386PubMed
27010203Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.Neurosurgery1981https://conductscience.org/library/papers/7010203PubMed
34138300Letter: Epsilon-aminocaproic acid and subarachnoid haemorrhage.?211.Lancet1974https://conductscience.org/library/papers/4138300PubMed
45790480The use of antifibrinolytic substances in ruptured intracranial aneurysms.Neurochirurgia (Stuttg)1969https://conductscience.org/library/papers/5790480PubMed
57376944Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7376944PubMed
6505491Tranexamic acid in subarachnoid hemorrhage. A double-blind study.Stroke1979https://conductscience.org/library/papers/505491PubMed
74830928Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania.Med J Aust1974https://conductscience.org/library/papers/4830928PubMed
8346153Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?Br Med J1978https://conductscience.org/library/papers/346153PubMed
95041103The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy.Br J Surg1972https://conductscience.org/library/papers/5041103PubMed
1085988Prevention of early recurrence of spontaneous subarachnoid haemorrhage by epsilon-aminocaproic acid.Lancet1979https://conductscience.org/library/papers/85988PubMed
1181287Antifibrinolytic therapy of subarachnoid hemorrhage by intrathecal administration of p-aminomethylbenzoic acid.J Neurol1978https://conductscience.org/library/papers/81287PubMed
125639737Antifibrinolytic therapy for intracranial aneurysms.J Neurosurg1968https://conductscience.org/library/papers/5639737PubMed
134784923The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms.Trans Am Neurol Assoc1973https://conductscience.org/library/papers/4784923PubMed
141198627Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.Stroke1975https://conductscience.org/library/papers/1198627PubMed
155576488Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms.Postgrad Med J1971https://conductscience.org/library/papers/5576488PubMed
16365072Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.Ann Neurol1977https://conductscience.org/library/papers/365072PubMed
176402715Progressive change in cerebral blood flow during the first three weeks after subarachnoid hemorrhage.Neurosurgery1983https://conductscience.org/library/papers/6402715PubMed
18354483Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.Ann Neurol1978https://conductscience.org/library/papers/354483PubMed
196166061The role of antifibrinolytic therapy in the preoperative management of recently ruptured intracranial aneurysms.Surg Neurol1981https://conductscience.org/library/papers/6166061PubMed
206179402Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/6179402PubMed

See all 40 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.

PMIDTitleJournalYearIn PapersSource
42616160Tranexamic acid after aneurysmal subarachnoid hemorrhage is associated with worse outcome in males: post hoc analysis of the ULTRA trial.J Neurol2026https://conductscience.org/library/papers/42616160PubMed
42568002Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials.J Thromb Thrombolysis2026https://conductscience.org/library/papers/42568002PubMed
42095754
European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage.
Eur Stroke J2026https://conductscience.org/library/papers/42095754PubMed
41134732Sex Disparities in Intracranial Aneurysm Trial Participation: A Systematic Review and Meta-Analysis.Cerebrovasc Dis2026https://conductscience.org/library/papers/41134732PubMed
40599738Efficacy and safety of tranexamic acid administration for subarachnoid hemorrhage: a systematic review and meta-analysis.Front Neurol2025https://conductscience.org/library/papers/40599738PubMed
40316838Relationship between Tranexamic Acid Use and Safety in Patients with Acute Brain Injury: A Systematic Review and Meta-analysis of Mortality and Thromboembolic Events.CNS Drugs2025https://conductscience.org/library/papers/40316838PubMed
39564438The efficacy and application of tranexamic acid in emergency medicine: Emergency Medicine Association of Türkiye clinical policy- 2024.Turk J Emerg Med2024https://conductscience.org/library/papers/39564438PubMed
37228855The efficacy of antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.Future Sci OA2023https://conductscience.org/library/papers/37228855PubMed
37202712Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage.Neurocrit Care2023https://conductscience.org/library/papers/37202712PubMed
37000863Efficacy and safety of tranexamic acid in intracranial haemorrhage: A meta-analysis.PLoS One2023https://conductscience.org/library/papers/37000863PubMed
36350005Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36350005PubMed
35140671Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.Front Neurol2021https://conductscience.org/library/papers/35140671PubMed
35083272Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Front Surg2021https://conductscience.org/library/papers/35083272PubMed
34677620Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine.Intensive Care Med2021https://conductscience.org/library/papers/34677620PubMed
34315966Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis.Sci Rep2021https://conductscience.org/library/papers/34315966PubMed
34221603Effect of tranexamic acid on blood loss, coagulation profile, and quality of surgical field in intracranial meningioma resection: A prospective randomized, double-blind, placebo-controlled study.Surg Neurol Int2021https://conductscience.org/library/papers/34221603PubMed
33851983Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression.JAMA Surg2021https://conductscience.org/library/papers/33851983PubMed
30741383Tranexamic Acid in Cerebral Hemorrhage: A Meta-Analysis and Systematic Review.CNS Drugs2019https://conductscience.org/library/papers/30741383PubMed
28261426Is Intraoperative Use of QuikClot Combat Gauze Effective for Hemostasis after Total Knee Arthroplasty?Clin Orthop Surg2017https://conductscience.org/library/papers/28261426PubMed
26937276Advances in the understanding of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage.F1000Res2015https://conductscience.org/library/papers/26937276PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2407050

GET https://conductscience.org/api/papers/v1/2407050/references?page=2